Catalent, Inc. to Present at the Morgan Stanley 2014 Global Healthcare Conference
25 August 2014 - 10:00PM
Business Wire
Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global
provider of advanced delivery technologies and development
solutions for drugs, biologics and consumer health products, today
announced that John Chiminski, President & Chief Executive
Officer, and Matthew Walsh, Executive Vice President & Chief
Financial Officer, will present at the Morgan Stanley 2014 Global
Healthcare Conference at 12:55 p.m. ET on Wednesday, September 10,
2014.
A live webcast of Catalent’s presentation can be accessed from
the Company’s website at www.catalent.com and will be available for
replay later that day.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products. With over 80 years serving
the industry, Catalent has proven expertise in bringing more
customer products to market faster, enhancing product performance
and ensuring reliable clinical and commercial product supply.
Catalent employs more than 8,000 people, including over 1,000
scientists, at nearly 30 facilities across 5 continents. Catalent
is headquartered in Somerset, N.J. For more information, please
visit www.catalent.com.
Forward-Looking Statements
This press release contains both historical and forward-looking
statements. All statements other than statements of historical fact
are, or may be deemed to be, forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements generally can be identified by the
use of statements that include phrases such as “believe,” “expect,”
“anticipate”, “intend”, “estimate”, “plan”, “project”, “foresee”,
“likely”, “may”, “will”, “would” or other words or phrases with
similar meanings. Similarly, statements that describe our
objectives, plans or goals are, or may be, forward-looking
statements. These statements are based on current expectations of
future events. If underlying assumptions prove inaccurate or
unknown risks or uncertainties materialize, actual results could
vary materially from Catalent, Inc.’s expectations and projections.
Some of the factors that could cause actual results to differ
include, but are not limited to, the following: general industry
conditions and competition; product or other liability risk
inherent in the design, development, manufacture and marketing of
our offerings; inability to enhance our existing or introduce new
technology or services in a timely manner; economic conditions,
such as interest rate and currency exchange rate fluctuations;
technological advances and patents attained by competitors; and our
substantial debt and debt service requirements that restrict our
operating and financial flexibility and impose significant interest
and financial costs. For a more detailed discussion of these and
other factors, see the information under the caption “Risk Factors”
in our Prospectus dated July 30, 2014 filed with the Securities and
Exchange Commission. All forward-looking statements speak only as
of the date of this release or as of the date they are made, and
Catalent, Inc. does not undertake to update any forward-looking
statements as a result of new information or future events or
developments unless required by law.
More products. Better treatments. Reliably supplied.™
Investor:Bertner Advisors, LLCMonique Kosse,
860-940-0352Monique.Kosse@BertnerAdvisors.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024